| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1604566 | 6480464 | Ethinyl Estradiol affects the expression of STON2 mRNA | CTD | PMID:20170705 |
| 17beta-estradiol | decreases expression | ISO | RGD:1604566 | 6480464 | Estradiol results in decreased expression of STON2 mRNA | CTD | PMID:19167446 PMID:21185374 |
| 17beta-estradiol | decreases expression | ISO | RGD:1604566 | 6480464 | Estradiol results in decreased expression of STON2 mRNA | CTD | PMID:21185374 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of STON2 mRNA | CTD | PMID:20159946 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of STON2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1311502 | 6480464 | Tetrachlorodibenzodioxin affects the expression of STON2 mRNA | CTD | PMID:22298810 |
| bisphenol A | affects expression | ISO | RGD:1604566 | 6480464 | bisphenol A affects the expression of STON2 mRNA | CTD | PMID:20170705 |
| chloroprene | increases expression | ISO | RGD:1311502 | 6480464 | Chloroprene results in increased expression of STON2 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 |
| coumestrol | decreases expression | ISO | RGD:1604566 | 6480464 | Coumestrol results in decreased expression of STON2 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:1604566 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA | CTD | PMID:19167446 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of STON2 mRNA | CTD | PMID:20938992 |
| lead(0) | decreases expression | ISO | RGD:1604566 | 6480464 | Lead results in decreased expression of STON2 mRNA | CTD | PMID:19921347 |
| maneb | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] affects the expression of STON2 mRNA | CTD | PMID:22563483 |
| paraquat | multiple interactions | EXP | | 6480464 | [Paraquat co-treated with Maneb] affects the expression of STON2 mRNA | CTD | PMID:22563483 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of STON2 mRNA | CTD | PMID:22563483 |
| pyridaben | increases expression | EXP | | 6480464 | pyridaben results in increased expression of STON2 mRNA | CTD | PMID:22563483 |